Founded in 2003 as DNA2.0 and later rebranded to ATUM, the company is a leader in the field of synthetic biology. Its mission is to provide researchers with advanced tools and services to engineer biology, thereby accelerating scientific discovery and the development of new therapeutics, industrial enzymes, and agricultural products. ATUM integrates proprietary AI-based software for gene design with automated lab processes to offer a comprehensive suite of solutions, including gene synthesis, protein expression optimization, and stable cell line development.

Founded in

United States